← Back to headlines
Finland Investigates Cancer Drug Reimbursement Controversy
Yle investigated the background of a 'cancer drug controversy' in Finland, revealing that the issue primarily stems from an increase in the cost of one specific cancer medication, with more new drugs expected to be unreimbursed by Kela.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
US and Iran Resume Direct Military Strikes as Oil Prices Surge
20m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
2h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago